Resmed (RSMDF) EBIT Margin Growth (5y) (2014 - 2026)
Analysis
Resmed (RSMDF) EBIT Margin Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.05 Bn | 178.45 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.38 Bn | 119.17 Bn | 1.96 Bn |
| 3 | Medtronic | 118.39 Bn | 109.58 Bn | 6.34 Bn |
| 4 | Stryker | 105.69 Bn | 102.21 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.59 Bn | 66.05 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.78 Bn | 45.53 Bn | 1.35 Bn |
| 7 | Alcon | 33.98 Bn | 32.53 Bn | 1.68 Bn |
| 8 | Dexcom | 32.21 Bn | 30.26 Bn | 830.00 Mn |
| 9 | Steris | 21.12 Bn | 20.64 Bn | 684.20 Mn |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 308.00 |
| Mar 31, 2026 | 585.00 |
| Dec 31, 2025 | 684.00 |
| Sep 30, 2025 | 459.00 |
| Jun 30, 2025 | 474.00 |
| Mar 31, 2025 | 473.00 |
| Dec 31, 2024 | 567.00 |
| Sep 30, 2024 | 651.00 |
| Jun 30, 2024 | 1,399.00 |
| Mar 31, 2024 | 759.00 |
| Dec 31, 2023 | -47.00 |
| Sep 30, 2023 | 172.00 |
| Jun 30, 2023 | 98.00 |
| Mar 31, 2023 | 387.00 |
| Dec 31, 2022 | 282.00 |
| Sep 30, 2022 | 752.00 |
| Jun 30, 2022 | 504.00 |
| Mar 31, 2022 | 621.00 |
| Dec 31, 2021 | 952.00 |
| Sep 30, 2021 | 875.00 |